Sign in
4

Changes in Ownership

Atrium Therapeutics, Inc. Filed Acc 0001193125-26-397955

Director gave up 22,812 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Flanagan W. Michael Director 2026-09-18 Shares withheld for taxes −22,812 $8.95 $204,167 31,974 D
Loading xslF345X06/ownership.xml…